Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 7/20 | 0.50 |
| ▸ | PPARG | P37231 | 1/20 | 0.50 |
| ▸ | PPARA | Q07869 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 5/20 | 0.45 |
| ▸ | CNR2 | P34972 | 3/20 | 0.44 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21864130 | 0.88 | PTGS2 (0.51) | PTGS2PPARGPPARACYP3A4ALOX5 | |
| SCHEMBL5514786 | 0.82 | PTGS2 (0.61) | PTGS2PPARGPPARAALOX5 | |
| SCHEMBL10774727 | 0.81 | PTGS2 (0.59) | PTGS2PPARGPPARAALOX5 | |
| SCHEMBL10772012 | 0.81 | PTGS2 (0.59) | PTGS2PPARGPPARAALOX5 | |
| SCHEMBL10773005 | 0.81 | PTGS2 (0.59) | PTGS2PPARGPPARAALOX5 | |
| SCHEMBL28770054 | 0.81 | ALOX5 (0.62) | PTGS2PPARGPPARACYP3A4ALOX5 | |
| SCHEMBL19348319 | 0.79 | PPARG (0.53) | PTGS2PPARGPPARACYP3A4ALOX5 | |
| SCHEMBL23068241 | 0.78 | ALOX5 (0.66) | PTGS2CYP3A4ALOX5TNKS2 | |
| SCHEMBL11864023 | 0.78 | PPARG (0.48) | PTGS2PPARGPPARACYP3A4ALOX5 | |
| SCHEMBL21864134 | 0.78 | GPR84 (0.47) | PTGS2PPARGPPARACYP3A4ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210276936-A1 | Synthesis of Cannabigerol | TREEHOUSE BIOTECH, INC. | 2021-09-09 | — | — | US | disclosed |
| US-20210276936-A1 | Synthesis of Cannabigerol | TREEHOUSE BIOTECH, INC. | 2021-09-09 | — | — | US | disclosed |
| EP-3864000-A1 | SYNTHESIS OF CANNABIGEROL | CANOPY HOLDINGS, LLC (US) | 2021-08-18 | — | — | EP | disclosed |
| US-11040932-B2 | Synthesis of cannabigerol | TREEHOUSE BIOTECH, INC. (US) | 2021-06-22 | — | — | US | disclosed |
| US-11040932-B2 | Synthesis of cannabigerol | TREEHOUSE BIOTECH, INC. (US) | 2021-06-22 | — | — | US | disclosed |
| US-20200115306-A1 | SYNTHESIS OF CANNABIGEROL | TREEHOUSE BIOTECH, INC. | 2020-04-16 | — | — | US | disclosed |
| US-20200115306-A1 | SYNTHESIS OF CANNABIGEROL | TREEHOUSE BIOTECH, INC. | 2020-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200115306-A1 | SYNTHESIS OF CANNABIGEROL | COASY, ACSL3, SQLE | PTGS2 248/4885PPARG 441/4885PPARA 395/4885 |
| US-11040932-B2 | Synthesis of cannabigerol | COASY, ACSL3, SQLE | PTGS2 248/4885PPARG 441/4885PPARA 395/4885 |
| US-20210276936-A1 | Synthesis of Cannabigerol | COASY, ACSL3, SQLE | PTGS2 248/4885PPARG 441/4885PPARA 395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.